Font Size:
a
A
A
Keyword [Non-small]
Result: 161 - 180 | Page: 9 of 10
161.
δ-catenin Promotes Malignant Phenotype Of Non-small Cell Lung Cancer By Non-competitive Binding To E-cadherin With P120ctn In Cytoplasm
162.
Involvement Of Hsa-miR-125a-3p And Hsa-miR-125a-5p In Non-small Cell Lung Cancer
163.
The Relationship Between HDPR1 With Catenin Family Members Each Other In Non-Small Cell Lung Cancer
164.
Initial Partial Response And Stable Disease Indicate Similar Progression-free Survival For Chemotherapeutical Patients With Advanced Non-small Cell Lung Cancer
165.
Expression Of 14-3-3zeta And Its Influence On Tumor Development And Apoptosis In Stage T
1
Non-small Cell Lung Cancer
166.
Expression And Clinical Significance Of Survivin,P53 And Bcl-2 In ⅢA Non-small Cell Lung Cancer(NSCLC)before And After Neoadjuvant Chemotherapy
167.
The Mechanism Of Gefitinib Resistance Induced By Hepatocyte Growth Factor In Sensitive Non-small Lung Cancer Cells
168.
Hepatocellular Careinoma HepG2 Therapy Mediated By Tumor Suppressor Of Non-small Cell Lung Cancer 1
169.
Effect Of NKTm Cells Plus Cisplatin/cetuximab Treatment On NSCLC Cells In Vitro
170.
Concurrent Chemoradiotherapy For Locally Advanced Non-small Cell Lung Cancer Clinical Outcomes Of Patients With Malignant Lung Lesions Treated With Stereotactic Body Radiation Therapy
171.
Expression Of Nm23 And E-cadherin In Stage Ⅰ Non-small Cell Lung Cancer, And Their Relationship With Lymph Node Micrometastasis And Prognosis
172.
Anti-tumor Activity Of Fucoxanthin, An Active Ingredient Of Kelp Extract, Against Human NSCLC And Its Mechanism
173.
Detection And Identification Of Serum Biomarkers Of Non-small Cell Lung Cancer
174.
The Effect And Mechanism Of Inhibition Of Human Non-small Lung Cancer Cells By Vascular Basement Membrance Derived Multifunctional Peptide
175.
Research Of Health Technology Assessment For PET-CT In The Diagnosis Of Non-small Cell Lung Cancer
176.
The Efficacy Prediction Of Tyrosine Kinase Inhibitor For Treatment Of Advanced Non-small Cell Lung Cancer And The Related Basic Research
177.
The Changes Of CD4~+CD25~+ Regulatory T Cells Of Non Small-cell Lung Cancer Patients And The Effects Of CpG ODN
178.
Anti-Paclitaxel Resistance Effect Of Somatostatin Receptors Mediated Targeted Therapy On Non-small Cell Lung Cancer Cells And Its Possible Mechanisms
179.
Functional Imaging And Proteomics Techniques Predict Sensitivity To Chemoradiotherapy In Non-Small Cell Lung Cancer
180.
Combined Epidermal Growth Factor Receptor Targeting With The Tyrosine Kinase Inhibitor And The Monoclonal Antibody In No-Small Cell Lung Cancer
<<First
<Prev
Next>
Last>>
Jump to